Cognito Therapeutics, a clinical-stage medical device company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, today announced the presentation of new CSF proteomic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback